Meeting
2023 ASCO Quality Care Symposium
Measuring substance use disorder (SUD) in commercial and Medicaid insured patients with cancer in Washington state.
Authors
Li Li
Fred Hutchinson Cancer Research Center, Seattle, WA
Li Li, Catherine R. Fedorenko, Karma L. Kreizenbeck, Veena Shankaran, Scott David Ramsey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Cancer Outcome Disparities
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 177)
DOI
10.1200/OP.2023.19.11_suppl.177
Abstract #
177
Poster Bd #
E16
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Exploring cost and utilization outcomes of Huntsman at Home: Which patients benefit most from a novel oncology hospital at home program?
First Author: Brock ONeil
Poster
2024 ASCO Annual Meeting
Dose-expansion part of a phase 1b global study of E7386 in combination with lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC) and other solid tumors including endometrial cancer (EC).
First Author: Jung-Yun Lee
Poster
2023 ASCO Quality Care Symposium
Prospective validation of machine learning-based approaches to predict potentially preventable emergency visits and hospitalizations.
First Author: Isabel D Friesner
Poster
2023 ASCO Quality Care Symposium
The association between telemedicine visits and downstream utilization among patients with cancer at a large academic health center.
First Author: Preeti Kakani